Cite
HARVARD Citation
Vidal-Jordana, A. et al. (2015). Significant clinical worsening after natalizumab withdrawal: Predictive factors. Multiple sclerosis. pp. 780-785. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Vidal-Jordana, A. et al. (2015). Significant clinical worsening after natalizumab withdrawal: Predictive factors. Multiple sclerosis. pp. 780-785. [Online].